For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240108:nRSH9678Ya&default-theme=true
RNS Number : 9678Y Deutsche Bank AG, Frankfurt 08 January 2024
08 January 2024
Not for distribution, directly or indirectly, in or into the United States or
any jurisdiction in which such distribution would be unlawful
Ephios Subco 3 S.à r.l.
Post-Stabilisation Notice
Pursuant to Article 6(3) of Commission Delegated Regulation (EU) 2016/1052
supplementing Article 5 of Regulation (EU) No 596/2014 of the European
Parliament and of the Council with regard to regulatory technical standards
for the conditions applicable to buy-back programmes and stabilisation,
Deutsche Bank Aktiengesellschaft (contact: Jeremy Selway, telephone +44 (0)20
7547 5983) hereby gives notice that no stabilisation was undertaken by the
Stabilising Manager named below in relation to the offer of the following
securities.
Issuer:
Ephios Subco 3 S.à r.l.
Guarantors (if any): Institut für medizinische
und chemische Labordiagnostik Gesellschaft m.b.H.; SYNLAB Belgium SRL; SYNLAB
AG; Medizinisches Versorgungszentrum SYNLAB Leverkusen GmbH; SYNLAB
Medizinisches Versorgungszentrum Augsburg GmbH; SYNLAB Medizinisches
Versorgungszentrum Heidelberg GmbH; SYNLAB Medizinisches
Versorgungszentrum Leinfelden-Echterdingen GmbH; SYNLAB Medizinisches
Versorgungszentrum Trier GmbH; SYNLAB Medizinisches Versorgungszentrum
Weiden GmbH; SYNLAB Nord de France SELAS; SYNLAB Nouvelle-Aquitaine SELAS;
SYNLAB Provence SELAS; E4Law Limited; Integrated Pathology Partnerships
Limited; Data Medica Padova S.p.A.; Synlab Italia S.r.l.; Synlab Lazio
S.r.l.; Synlab MED S. r. l.; SYNLAB SDN S.p.A.;
Aggregate nominal amount: €450,000,000.00
Description: EUR
450,000,000 Senior Secured Fixed Rate Notes 7.875% due 2031 (RegS ISIN:
XS2734938249; 144A ISIN: XS2734938678)
Issue/Reoffer Price: 100 / 100
Spread over benchmark: +574 bps
Stabilising Manager(s): Deutsche Bank Aktiengesellschaft
This announcement is for information purposes only and does not constitute an
invitation or offer to underwrite, subscribe for or otherwise acquire or
dispose of any securities of the Issuer in any jurisdiction.
This announcement is not an offer of securities for sale into the United
States. The securities referred to above have not been, and will not be,
registered under the United States Securities Act of 1933 and may not be
offered or sold in the United States absent registration or an exemption from
registration. There has not been and will not be a public offer of the
securities in the United States.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END STAFLFLFLRITIIS